BAC vs MS: How Bank of America and Morgan Stanley Compare (2026)

Same yardstick, side by side (as of July 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.

Reading it: BAC is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.

The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. BAC and MS share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.

This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined BAC and MS exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.

Bank of America is the second-largest US bank by assets, behind JPMorgan Chase. The company is one of the four mega-bank holding companies (along with JPMorgan, Citigroup, and Wells Fargo) and operates across four main reporting segments. Consumer Banking is the largest retail bank in the US by deposits, serving over 60 million customers through ~3,800 branches. Global Wealth and Investment Management is one of the largest US wealth managers (anchored by Merrill Lynch). Global Banking provides commercial banking, treasury services, and investment banking to corporate and institutional clients. Global Markets provides trading services across fixed income, equities, and commodities.

Full BAC guide

Morgan Stanley is a global financial services firm founded in 1935 and headquartered in New York City, with offices in 42 countries and more than 80,000 employees. It operates through three segments: Institutional Securities (investment banking, equity and fixed-income trading, prime brokerage, and research), Wealth Management (financial-advisor-led brokerage, investment advisory, lending, and banking services for individuals and families), and Investment Management (equity, fixed income, alternatives, and liquidity strategies for institutions and intermediaries). The firm earns revenue through advisory and underwriting fees, trading gains, and, increasingly, recurring asset-based fees tied to the value of client assets across its wealth and investment management platforms. The current Morgan Stanley took its modern shape through the 1997 merger with Dean Witter Discover and a string of subsequent acquisitions, most notably E*TRADE (2020) and Eaton Vance (2021), which dramatically expanded its self-directed brokerage and asset management capabilities. Ted Pick became Chairman and CEO at the start of 2024, succeeding James Gorman, who had led the firm since 2010 and orchestrated its transformation toward fee-based businesses. Under Pick, the integrated-firm strategy emphasizes cross-selling across all three segments and driving client assets toward fee-based relationships to generate more predictable earnings.

Full MS guide

Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.

• BAC drivers: Net interest income from deposit franchise; Investment banking and trading recovery.
• MS drivers: Wealth management as a recurring-revenue engine; Capital-markets cycle recovery.

A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. The honest test is which set of risks you could hold through a drawdown: Credit quality is the eternal bank risk; consumer and commercial credit losses cyclically. For MS, a simultaneous downturn in asset prices and capital-markets activity would pressure both the fee-based wealth revenues and the transaction-dependent Institutional Securities segment at the same time, which is the scenario that most concerns long-term holders.

Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick BAC if you believe its drivers more; MS if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the BAC and MS guides.

BAC. BAC trades at a modest P/E typical of large US banks. The valuation balances the durable consumer deposit franchise and capital markets recovery against credit cycle uncertainty and regulatory capital requirements. Price-to-book around 1.1x is consistent with ROE around 10%.

MS. Morgan Stanley's trailing P/E of roughly 19 to 20 times sits modestly above its own 5-year historical average of around 14 to 15 times, reflecting the market's recognition of the firm's successful shift toward more durable, fee-based earnings. The ROTCE of 21.6% for full-year 2025 demonstrates that the integrated-firm model is generating returns well above most peers' cost of equity, though sustaining that level depends on continued strength in both capital markets and wealth inflows. At a forward P/E of approximately 17.6 times, the stock is not priced as a deep-value name, meaning expectations for continued earnings growth are already embedded in the current price.

Headline figures (approximate, early 2026): BAC shows revenue (ttm) ~$100 billion, net income (ttm) ~$28 billion, eps (ttm) ~$3.50, p/e (ttm) ~13x; MS shows revenue (full year 2025) ~$70.6 billion, net income (full year 2025) ~$13.4 billion (approx., based on ~$10.21 EPS on ~1.58B diluted shares), eps (ttm) ~$11.04, p/e ratio (ttm) ~19-20x.

BAC and MS are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined BAC and MS exposure against your real portfolio. It is not an investment adviser.